Skip to main content
Top
Gepubliceerd in: Journal of Foot and Ankle Research 1/2023

Open Access 01-12-2023 | Commentary

A novel assessment, diagnostic and treatment system for diabetic foot

Auteurs: Jordi Viadé, Maria Nicolás, Magdalena Bundó, Marc Sirvent, Clàudia Riera, Miquel Sabriá

Gepubliceerd in: Journal of Foot and Ankle Research | Uitgave 1/2023

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
insite
ZOEKEN

Abstract

Background

This report aims to present a novel system for the management of foot lesions in patients with diabetes. It was developed in the diabetic foot unit (DFU) of the Mutua de Terrassa University Hospital (HUMT) by primary care professionals, the Diabetic Foot Clinic (DFC), and during emergency cases treated by our group based on daily activities in patients with neuropathy or neuroischemia.

Body

This system considers five degrees of action based on two fixed variables: presence of infection and lesion depth. These two variables allowed the user to investigate aspects of the system until the overall action required by the pathology is made clear. These variables establish pathology stages of various severities that require different actions in aspects of care, management and treatment.

Conclusion

This tool facilitates diagnosis, treatment, and coordination among different members of a multidisciplinary team working in specialized hospital units, primary care centers, and emergency settings.
Opmerkingen

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Afkortingen
DF
Diabetic Foot
DFC
Diabetic Foot Clinic
DM
Diabetes Mellitus
DFU
Diabetic Foot Unit
HUMT
Mutua de Terrassa University Hospital
HUGTP
Germans Trias I Pujol University Hospital
G
Ulcer grade
G1
Ulcer grade one
G2
Ulcer grade two
G3
Ulcer grade three
LOPS
Loss of protective sensation
WIFI
Wound depth, ischemia and foot infection
IWGDF
International Working Group on Diabetic Foot
PEDIS
Perfusion, extent, depth, infection, and sensation
SINBAD
Site, ischaemia, neuropathy, bacterial infection, area, and depth

Background

Diabetic foot (DF) is a major cause of morbidity and mortality in patients with diabetes mellitus (DM) [1]. Most patients develop foot ulcers after age 40, and the risk increases with age [2]. The most comprehensive definition of DF, in our opinion, is “the presence of signs, symptoms, or foot ulcers as a result of chronic complications of diabetes” [3].
DF has a multicausal origin and is progressive. Deformities or changes in plantar pressure distribution, a general lack of sensitivity and the presence of an underlying vegetative and vascular disorder, can all accelerate fissuring of the horny layer. This can create a lesion that progresses toward deeper soft tissues and can reach the bone [35], putting the limb and even the life of the patient at risk [6].
Multiple classifications or scales have been published to establish the risk and severity of DF-related injury, or as a means of communication between professionals [79]; however, there is currently no universally-accepted classification [9].
We present a system for the evaluation and treatment of foot lesions in patients with DF that facilitates diagnosis and treatment, as well as coordination and management between members of multidisciplinary teams and healthcare professionals in primary and/or emergency care centers. It has been used by researchers for over 20 years, and its implementation in a multidisciplinary team has led to a considerable reduction in the number of major amputations [10].

The system

In 1992, a diabetic foot unit (DFU) was established at Mutua de Terrassa University Hospital (HUMT), comprising an endocrinologist, a nurse educator, and a specialist podiatrist. To facilitate coordination between the different care areas, a system was created to evaluate and treat foot complications in patients with DF. Over years of continuous training, clinical practice, and with the contributions of certain specialisties in the vascular surgery and infectious diseases unit, the system was further expanded. Beginning in 2013, the German Trias i Pujol Hospital organized a multidisciplinary DF team and decided to implement the evaluation and treatment system used in HUMT for its operations as well. More specialists were incorporated including plastic surgery, diagnostic imaging, traumatology, home care, nutrition, social work, and rehabilitation. With the collaboration of these diverse specialties, a revision and expansion of the system was carried out (Table 1).
Table 1
Diabetic foot evaluation and treatment system
Ulcer grade
0
1
2
3
4
CHARACTERISTICS
DEPTH
No ulcer
Epidermis/Dermis
G1 + Subcutaneous tissue
G2 + Fascia/Muscle/Bone
G3 + Critical ischaemia? Yes/No
 
Warmth, oedema, erythema. DISMISS
Signs of ischemiaa
Signs of ischemiaa
Signs of ischemiaa
and/or Necrosis areas
INFECTION?
Assess
No
Superficial
Deep/Located
and/or Systemic toxicity
EVALUATION
Neuroischemic screenig
Skin thermometry
Neuroischemic screening
Neuroischemic screening
Neuroischemic screening
Neuroischemic screening
Charcot Neuro-arthropathy?
Image diagnosis
 
Microbiological Culture
Microbiological Culture
Microbiological Culture
Probe to bone
Probe to bone
Probe to bone
TREATMENT
Suspicion of Charcot neuro-arthropathy:
  
Debridement, surgery
Debridement and/or Revascularization
Oral antibiotic
Oral antibiotic/IV
Antibiotic IV
Tie up
Dressings
Dressings
Dressings
Dressings
Surgery?
Offloading
Offloading
Offloading
 
Relative rest
Absolute rest
CARE LEVEL
Primary care/ DFU/ Hospital
Primary care
Primary care/ DFU
DFU/ Hospital
Hospital/ DFU
DIABETES EDUCATION
Review
Review
Review
Review
Review
G Ulcer Grade, IV intravenous, DFU Diabetic Foot Unit
aSigns of ischemia = Consider one more grade
The system considers five degrees of action based on two fixed variables: the presence of infection and the lesion depth. Both allow users to investigate other aspects of the system until the overall action required by the pathology is made clear. These variables establish DF stages of different severities that require different actions in terms of care, management, and treatment.
The evaluation includes important aspects such as neuroischemic screening, microbiological culture, probe to bone or image scans to rule out the presence of osteomyelitis or neuroarthropathy. It also includes the different therapeutic actions recommended for each stage or grade, ranging from the type of offloading to topical wound dressings or oral antibiotics.
The complete system table (Table 1) shows the most appropriate level of treatment depending on the degree of DF, as well as a reminder regarding the importance of diabetes education. The podiatrist or nurse educator provides support care for hygiene measures, hydration, recognition of warning signs, and footwear—all of which help avoid recurrences.
Grade 0 rules out the presence of Charcot neuroarthropathy or underlying infections without ulcerations. This grade is used for the diagnosis of phase 0 of Charcot foot or infection without ulceration. If there is an ulcer, the following grades are used: grade 1 for non-infected superficial ulcers; grade 2 for ulcers that reach the subcutaneous tissue with signs of superficial infection; grade 3 for ulcers that reach the fascia, muscle, and/or bone with localized deep infection; and grade 4 for those with systemic involvement, critical ischemia or necrosis.
Patients with insufficient blood supplies should be considered and treated as higher-grade, because the presence of arterial ischemia worsens the prognosis [9].
This system table includes eight complementary tables (neuroischemic screening, diagnosis of Charcot neuroarthropathy, sample collection for microbiological culture, diagnosis of osteomyelitis, offloading systems, oral antibiotics, topical treatment, and surgical techniques) that add to content and help determine generalized treatments.

Discussion

The goal of developing this system was to guide healthcare professionals, from primary care to the emergency room, in the generalized management of patients with DF who have suspected Charcot neuroarthropathy or foot ulcers, enabling them to act quickly [11] and thus maximize their chances of avoiding complications or the need for amputation.
Our system was not intended to be compared to other published classifications; it simply aims to offer a new tool for the management of this health problem, and has proven very useful in our DFU for a long period of time. As part of our tool comprises wound classification, we wanted to discuss the other most commonly used classifications currently used. In the scales published to date, certain essential aspects of clinical management have not been considered. For example, the wound depth, ischemia, and foot infection (WIFI) system [12] is a good option for assessing the level of ischemia and the benefit of revascularization; however, it does not include neuropathy, ulcer location, or ulcer extension. The International Working Group on Diabetic Foot (IWGDF) [13] classification only considers infection and does not assess other parameters that are important for the prognosis of ulcers—such as ischemia, neuropathy, location, depth, and extension of the ulcer. Although the University of Texas classification [14] is commonly used, it does not consider neuropathy or ulcer areas, which are major determinant of healing. Perfusion, extent, depth, infection, and sensation (PEDIS) [15] may be the most complete, although it is not easy to use in daily clinical practice and is most appropriate for determining the inclusion and exclusion criteria for research projects [8, 16]. The IWGDF currently recommends using the site, ischaemia, neuropathy, bacterial infection, area, and depth (SINBAD) classification because it includes the largest number of ulcer characteristics, and because it is a simple scoring system that is easy to use by any specialist. However, it does not provide 100% specific information on lesion characteristics, which is why it has been criticized for being insufficient [9].
The involvement of a multidisciplinary team can improve the prognosis of DF [17, 18]. Coordination between departments that care for patients with DF is therefore essential for its proper management.
Because these patients must be treated by a multidisciplinary team, unifying all variants in a single document, and considering the most appropriate level of care at each time point, makes handling their cases easier.
In many countries, the first contact between a patient and the health care system is through primary care [1]—which is often responsible for prevention, early detection, or referral to secondary level.
Our novel system is a tool that facilitates coordinated work among multidisciplinary teams to achieve the comprehensive management of patients with DF and decrease major amputation rates. In HUMT, between 2003 and 2012 when the system was first adopted, major amputations decreased by 67%—from 34 major amputations in 2003 to 11 in 2012. In HUGTP, from 2013–2021, the number of major amputations decreased from 153 (2010–2014) to 71(2015–2020) [10, 19].

Acknowledgements

Not applicable.

Declarations

Not applicable in this section.
Not applicable in this section.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
2.
go back to reference Mesa Pérez JA, Vitarella G, Rosas Guzmán J, et al. Guías ALAD de pie diabético. Asociación Latinoamericana de Diabetes; 2010 Mesa Pérez JA, Vitarella G, Rosas Guzmán J, et al. Guías ALAD de pie diabético. Asociación Latinoamericana de Diabetes; 2010
3.
go back to reference Viadé J, Royo J. Pie Diabético. Guía para la práctica clínica. 2a. In: Editorial, editor. Médica Pan americana; 2013. 187 p Viadé J, Royo J. Pie Diabético. Guía para la práctica clínica. 2a. In: Editorial, editor. Médica Pan americana; 2013. 187 p
6.
go back to reference Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, et al. Diabetic foot ulcers: Part I Pathophysiology and prevention. J Am Acad Dermatol. 2014;70(1):1.e1-18 quiz 19–20.CrossRefPubMed Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, et al. Diabetic foot ulcers: Part I Pathophysiology and prevention. J Am Acad Dermatol. 2014;70(1):1.e1-18 quiz 19–20.CrossRefPubMed
10.
go back to reference Viadé J, Valverde Torreguitart J, Royo Serrando M, Barahona Constanzo J, Balsells Coca M, Ventura MU, et al. P-092 El impacto de una unidad de pie diabetico en la prevalencia de amputaciones: evaluación a 6 años. Vigo: el Sevier Doyma En. 2012;64:23–81. Viadé J, Valverde Torreguitart J, Royo Serrando M, Barahona Constanzo J, Balsells Coca M, Ventura MU, et al. P-092 El impacto de una unidad de pie diabetico en la prevalencia de amputaciones: evaluación a 6 años. Vigo: el Sevier Doyma En. 2012;64:23–81.
18.
go back to reference Musuuza J, Sutherland BL, Kurter S, Balasubramanian P, Bartels CM, Brennan MB. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg April. 2020;71:1433-1446.e3.CrossRef Musuuza J, Sutherland BL, Kurter S, Balasubramanian P, Bartels CM, Brennan MB. A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg April. 2020;71:1433-1446.e3.CrossRef
Metagegevens
Titel
A novel assessment, diagnostic and treatment system for diabetic foot
Auteurs
Jordi Viadé
Maria Nicolás
Magdalena Bundó
Marc Sirvent
Clàudia Riera
Miquel Sabriá
Publicatiedatum
01-12-2023
Uitgeverij
BioMed Central
Gepubliceerd in
Journal of Foot and Ankle Research / Uitgave 1/2023
Elektronisch ISSN: 1757-1146
DOI
https://doi.org/10.1186/s13047-023-00687-z

Andere artikelen Uitgave 1/2023

Journal of Foot and Ankle Research 1/2023 Naar de uitgave